Table of Contents
1. Market Overview
1.1 Product Overview and Scope of Market
1.2 Global Market of Cancer Gene Therapy
2. Market Insights by Product Type
2.1 Market Revenue by Product Types:
2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
2.1.3 Graph Market Share (%) by Product Types in 2018
2.2 Market Volume by Product Types:
2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
2.2.3 Graph Market Share (%) by Product Types in 2018
2.3 Gene Induced Immunotherapy Market Analysis
2.3.1 Graph Global Gene Induced Immunotherapy Market Revenue (in million USD ) (2018-26)
2.3.2 Graph Global Gene Induced Immunotherapy Market Volume (in million units ) (2018-26)
2.3.3 Table Gene Induced Immunotherapy Market Geographical Analysis
2.4 Oncolytic Virotherapy Market Analysis
2.4.1 Graph Oncolytic Virotherapy Market Revenue (in million USD) (2018-26)
2.4.2 Graph Global Oncolytic Virotherapy Market Volume (in million Units ) (2018-26)
2.4.3 Table Oncolytic Virotherapy Market Geographical Analysis
2.5 Gene Transfer
3. Market Segment by Applications
• Hospitals
• Diagnostics Centers
• Research Institutes
3.1 Table Market Revenue (in million USD) by Application (Historic Data)
3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data)
3.3 Hospitals application/ end user analysis
3.3.1 Graph Global Hospitals Revenue (in million USD ) (2018-26)
3.3.2 Table Global Hospitals Geographical Analysis
3.4 Diagnostics Centers
3.4.1 Graph Global Diagnostics Centers Revenue (in million USD ) (2018-26)
3.4.2 Table Global Diagnostics Centers Geographical Analysis
3.5 Research Institutes
4. Regional Market Analysis
4.1.1 Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
4.1. North America Cancer Gene Therapy Market Analysis(2018-26)
4.1.1 USA
4.1.2 Canada
4.1.3 Mexico
4.2 Europe Cancer Gene Therapy Market Revenue Forecast (2018-27)
4.2.1 UK
4.2.2 Germany
4.2.3 France
4.2.4 Italy
4.2.5 Rest Of Europe
4.3 APAC Cancer Gene Therapy Market Revenue Forecast (2018- 2026)
4.3.1 China
4.3.2 Japan
4.3.3 India
4.3.4 Singapore
4.3.5 Malaysia
4.3.6 Rest Of APAC
4.4 Rest Of the World (ROW) Market Revenue Forecast (2018-2026)
4.4.1 Africa
4.4.2 Middle East
4.4.3 South America
5. Competitive Analysis
5.1 Adaptimmune
5.1.1 Overview :
5.1.2 Basic Company Information:
5.1.3 Financial Overview
5.1.3 Production Overview
5.1.4 Geography Revenue Mix ( 2018)
5.1.5Business Revenue Mix
5.1.6 Recent Development
5.2 GlaxoSmithKline
5.2.1 Overview :
5.2.2 Basic Company Information:
5.2.3 Financial Overview
5.2.4 Production Overview
5.2.5 Geography Revenue Mix ( 2018)
5.2.6 Business Revenue Mix
5.2.7 Recent Development
• Bluebird bio
• Merck
• Celgene
• Shanghai Sunway Biotech
• BioCancell
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
• OncoGenex Pharmaceuticals
• Genelux Corporation
• Cell Genesys
• Advantagene
• GenVec
• BioCancell
• Celgene
• Epeius Biotechnologies
• Introgen Therapeutics
• Ziopharm Oncology
• Shenzhen SiBiono GeneTech
• Altor Bioscience
6. Research Findings and Conclusion
6.1 Research Finding:
6.2 Conclusion:
7. Methodology and Data Source
7.1 Methodology/Research Approach
7.2 Research Programs/Design
7.3 Market Size Estimation
7.4 Market Breakdown and Data Triangulation
7.5 Data Source
7.5.1 Secondary Sources
7.5.2 Primary Sources
7.6 Disclaimer